Search
30 results
-
tau oligomers released from presynaptic terminals through direct binding to tau
matched in: search_vector
-
Alpha-theta entrainment therapy targets somatostatin (SST) interneurons to restore
matched in: search_vector
-
tau (MAPT) in Alzheimer's disease exploit the same synaptic
matched in: search_vector
-
tau protein clearance through enhanced phagocytic activity rather than glymphatic
matched in: search_vector
-
tau conformations. Non-pathogenic transferred tau lacks this exposed templating
matched in: search_vector
-
tau propagation becomes dramatically accelerated, explaining the highly variable lag between
matched in: search_vector
-
tau phosphorylation and prevents tau accumulation at CA3-CA1 Schaffer
matched in: search_vector
- Hypothesis Enhancing Heparan Sulfate 3-O-Sulfotransferase Activity to Competitively Block Tau-HSPG Interactions
tau aggregates in Alzheimer's disease relies critically on heparan
matched in: search_vector
-
This intervention targets somatostatin-positive (SST) interneurons in the stratum
matched in: search_vector
-
tau's abnormal interaction with the ESCRT machinery for exosomal
matched in: search_vector
-
This hypothesis combines the precision of transcranial focused ultrasound (tFUS
matched in: search_vector
-
convert seed-competent tau into transferable but weakly pathogenic tau.
matched in: search_vector
-
tau blocks LAMP2A → tau accumulates → more tau blocks LAMP2A. Additionally
matched in: search_vector
-
tau uptake and preserving intracellular cholinergic function. The molecular mechanism
matched in: search_vector
-
tau fragments and hyperphosphorylated tau species into CSF. However, this
matched in: search_vector
-
tau protein dysfunction specifically compromises dopaminergic neurotransmission through disrupted axonal
matched in: search_vector
-
tau-stabilizing immunophilins (FKBP51) from HSP90 while recruiting tau-destabilizing
matched in: search_vector
-
tau clearance efficiency. The mechanism begins with TREM2/DAP12 signaling in perivascular
matched in: search_vector
-
The HSP90 chaperone system, comprising HSP90AA1 and HSP90AB1 in complex
matched in: search_vector
-
tau (MAPT) via GSK3B activation and drives amyloid-beta (APP/ABCA1
matched in: search_vector
-
tau, α-synuclein, TDP-43) is determined by their distinct
matched in: search_vector
-
tau (via GSK3B) both suppress NRF2 transcription and promote KEAP1
matched in: search_vector
-
tau species are transferred between neurons but remain non-pathogenic
matched in: search_vector
-
The HSP70 chaperone system achieves selective recognition of pathogenic protein
matched in: search_vector
-
tau-independent cytoskeletal defects in neurodegeneration, and stabilizing MAP6-microtubule
matched in: search_vector
-
tau conformational epitopes and simultaneously possess membrane-disrupting activity could
matched in: search_vector
-
Tau-containing vesicles display aberrant sialylation patterns that can be targeted
matched in: search_vector
-
tau vesicle surfaces using targeted glycosidases could disrupt the molecular
matched in: search_vector
-
tau tangles that disrupt synaptic transmission and neuronal survival. This
matched in: search_vector
-
tau-containing complexes, selectively destabilizing tau-HSP90 interactions while preserving
matched in: search_vector